期刊文献+

蛋白激酶A抑制剂H-89的致心律失常效应及机制

The proarrhythmic effect and mechanism of PKA antagonist H-89
下载PDF
导出
摘要 目的观察蛋白激酶A(PKA)抑制剂H-89对大鼠心律和心肌细胞膜内向整流钾电流(Ik1)、钠钙交换体电流(INa/Ca)的影响,从而评估其药理学应用价值。方法成年sD大鼠麻醉后开胸取出心脏行Langendofff主动脉逆行灌流,记录心电图,观察-89给药20min内对离体心脏节律的影响。应用全细胞膜片钳技术观察H-89对胶原酶分解的大鼠心室肌细胞膜Ik1和INa/Ca的影响。结果1~10μmol/LH-89可在大鼠离体心脏诱发明显的心律失常,室性期前收缩(PVB)数目,室速(VT)、室颤(VF)持续时间和发生率呈浓度依赖性增高(P〈O.05)。膜片钳记录结果显示,H-89可浓度依赖性抑制I。(P〈0.05),在5μmol/L时即可完全阻断Ik1类似于0.5mmol/L氯化钡(BaCl2)的效应。但H-89(1-10μmol/L)对INa/Ca无明显作用(P〉O.05)。结论H-89对心肌细胞膜电流的异常扰动是其致心律失常风险的主要电生理.机制,可由PKA依赖性或非PKA依赖性药理学作用共同介导。 Objective To observe the effect of N-(2-p-bromo-cinnamylaminoethyl)-5-isoquinoline- sulfonamide (H-89), a potent and potentially selective inhibitor of Protein Kinase A (PKA), on rat heart rhythm and cardiac inward rectifier K+ current (IK1), Na+-Ca2+ exchanger current (INa/Ca). Methods Langendorff-perfused SD rat hearts were subjected to H-89 at 1-10μmol/L respectively for 20 minutes. The ECGs were recorded si- multaneously. Whole-cell patch clamp technique was used to investigate the effects of H-89 on cardiac IKI and INa/Ca in enzymatic dissociated rat ventricular myocytes. Results 'H-89 at 1-10 μmol/L displayed singnificant proar- rhythmic risk in ex vivo hearts, the total of PVB, the incidence and duration of VT and VF were increased con- centration-dependently(P〈0.05 ). Patch-clamp data showed H-89 at 1-10 μmol/L had no effect on Ik1 CP〉0.05 ) while inhibited IK1 in a concentration dependent manner(P〈0.05 ). At 5 μmol/L, H-89 completely blocked IK1(P〈 0.05) just as the action of 0.5 mmol/L BaC12. Conclusion The underlying mechanism of proarrhythmic risk of H- 89 is ascribed to the disturbance of membrane ion currents mediated by both PKA-dependent and PKA-indepen- dent pathway.
出处 《中国心血管病研究》 CAS 2010年第2期130-133,共4页 Chinese Journal of Cardiovascular Research
基金 山西省自然科学基金青年项目(2009021043-2)
关键词 蛋白激酶A 心律失常 膜片钳 离子电流 H-89 Protein kinase A Arrhythmia Patch clamp Ion current H-89
  • 相关文献

参考文献8

  • 1Hidaka H,Kobayashi R. Pharmacology of protein kinase in- hibitors. Annu Rev Pharmacol Toxicol, 1992, 32 : 377-397.
  • 2Curran J, Hinton MJ, Rios E, et al. β-Adrenergic enhancement of sarcoplasmic reticulum calcium Leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res, 2007,100 : 391-398.
  • 3Rossie S. Regulation of voltage-sensitive sodium and calcium channels by phos-phorylation. Adv Sec Mess Phospho Res, 1999,33 : 23-48.
  • 4Bracken N,Elkadri M, Hart G, et al. The role of constitutive PKA-mediated phosphorylation in the regulation of basal Ⅰ (Ca) in isolated rat cardiac myocytes. Br J Pharmacol,2006,148:1108-1115.
  • 5李妙龄,曾晓荣.膜片钳技术在心血管及药理学研究中的应用[J].中国心血管病研究,2007,5(9):698-700. 被引量:7
  • 6Pearman C,Kent W,Bracken N,et al. H-89 inhibits transient outward and inward rectifier potassium currents in isolated rat ventricular myocytes. Br J Pharmacol, 2006,148 : 1091-1098.
  • 7刘博,秦永文.基因易感性与获得性长QT间期综合征[J].中国心血管病研究,2008,6(7):556-558. 被引量:2
  • 8Seemann G, Sachse FB, Weiss DL, et al. Modeling of IK1 mutations in human left ventricular myocytes and issue. Am J Physiol Heart Circ Physiol, 2007,292 : H549-559.

二级参考文献19

  • 1李妙龄,曾晓荣,杨艳,刘智飞,周文,丁银元,裴杰.持续性心房颤动患者心房肌细胞L型钙通道电流变化的研究[J].中华心血管病杂志,2006,34(4):308-311. 被引量:17
  • 2[2]Hamil OP,Marty A,Neher E,et al.Improved patch-clamp techniques for high-resolusion current recording from cells and cellfree membrane patches.Pflugers Arch,1981,391:85-100.
  • 3[3]Sakmann B,Neker E.Single-channel recording.New York:Plenum,1983:16-24.
  • 4[4]Zhou Z,Neher E.Mobile and immobile Ca buffers in bovine adrenal chromaffin cells.J Physiol,1993,469:245-273.
  • 5[5]Gomma AH,Purcell HJ,Fox KM.Potassium channel openers in myocardial ischaemia:therapeutic potential of nicorandil.Drugs 2001,61:1705-1710.
  • 6[6]Rivolta I,Clancy CE,Tateyama M,et al.A novel SCN5A mutation associated with long QT23:altered inactivation kinetics and channel dysfunction.Physiol G enomics,2002,10:191-197.
  • 7[1]Roden DM.Drng-induced prolongation of the QT Interval.N Engl J Med,2004,350:1013-1022.
  • 8[3]Moss AJ,Kass RS.Long QT syndrome:from channels to cardiac arrhythmias.J Clin Invest,2005,115:2018-2024.
  • 9[4]Roden DM,Viswanathan PC.Genetics of acquired long QT syndrome.J Clin Invest,2005,115:2025-2032.
  • 10[5]Sanguinetti MC,Bennett PB.Antiarrhythmic drug target choices and screening.Cire.Res,2003,93:491-499.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部